Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
CAPS Rating:
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
RSS Headlines
Fool UK
Recs
Safe drug after many years of testing;FDA had no problems with it at the ad-com meeting on (5/10). People on panel had problems about cancer and valve problems because of consistant bashing by adversaries the prior year. FDA was satisfied with the CRL from Arena.
I agree!!!!!!!!It's a great drug which will help everyone with the problem of obesity , it will also help people with other addictions as well.